Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 7/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.53 |
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | MEN1 | O00255 | 5/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.50 |
| ▸ | CDC25B | P30305 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | EGFR | P00533 | 3/20 | 0.48 |
| ▸ | PABPC1 | P11940 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | NSD2 | O96028 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 3/20 | 0.48 |
| ▸ | APAF1 | O14727 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | THRB | P10828 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL978805 | 0.91 | MAPT (0.57) | ADORA2AMAPTALDH1A1L3MBTL1LMNA | |
| SCHEMBL1038974 | 0.91 | ADORA2A (0.57) | ADORA2AMAPTALDH1A1L3MBTL1LMNA | |
| Ammonia Solution, Strong SCHEMBL27523091 | 0.89 | ADORA2A (0.55) | ADORA2AMAPTALDH1A1L3MBTL1LMNA | |
| SCHEMBL22797324 | 0.89 | HDAC4 (0.50) | MAPTALDH1A1L3MBTL1LMNAMEN1 | |
| SCHEMBL29595074 | 0.87 | LMNA (0.59) | ADORA2AMAPTALDH1A1L3MBTL1LMNA | |
| SCHEMBL11424452 | 0.87 | HDAC4 (0.52) | ADORA2AMAPTALDH1A1L3MBTL1LMNA | |
| SCHEMBL29836726 | 0.87 | MEN1 (0.67) | ADORA2AMAPTALDH1A1L3MBTL1LMNA | |
| SCHEMBL9335085 | 0.87 | MEN1 (0.67) | ADORA2AMAPTALDH1A1L3MBTL1LMNA | |
| SCHEMBL5010110 | 0.87 | MEN1 (0.67) | ADORA2AMAPTALDH1A1L3MBTL1LMNA | |
| SCHEMBL12626745 | 0.85 | MAPT (0.52) | ADORA2AMAPTALDH1A1L3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1947076-B1 | PROCESS FOR PRODUCING AROMATIC COMPOUNDS | IDEMITSU KOSAN CO (JP) | 2014-08-13 | — | — | EP | disclosed |
| US-20090206748-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND AND AROMATIC COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2009-08-20 | — | — | US | disclosed |
| US-7547809-B2 | Method for producing aromatic compound and aromatic compound | IDEMITSU KOSAN CO., LTD. (JP) | 2009-06-16 | — | — | US | disclosed |
| EP-1947076-A1 | PROCESS FOR PRODUCING AROMATIC COMPOUND AND AROMATIC COMPOUND OBTAINED BY THE PROCESS | Idemitsu Kosan Co., Ltd. (JP) | 2008-07-23 | — | — | EP | disclosed |
| US-20070060777-A1 | Method for producing aromatic compound and aromatic compound | IDEMITSU KOSAN CO., LTD. (JP) | 2007-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070060777-A1 | Method for producing aromatic compound and aromatic compound | TYR, DDC, DDT | ADORA2A 3913/4885MAPT 1690/4885ALDH1A1 827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.